Predictors of Hospital-Acquired Urinary Tract-Related Bloodstream Infection
医院获得性尿路相关血流感染的预测因子
基本信息
- 批准号:7655520
- 负责人:
- 金额:$ 22.8万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2008
- 资助国家:美国
- 起止时间:2008-07-15 至 2011-06-30
- 项目状态:已结题
- 来源:
- 关键词:AccountingAddressAdrenal Cortex HormonesAdultAffectAgeAllogenicAntibiotic ResistanceAntibioticsBacteriuriaBladderBlood CirculationBlood PlateletsBlood TransfusionBody mass indexCatheterizationCathetersClinicalComorbidityComplications of Diabetes MellitusDataDatabasesDecision MakingDetectionDevelopmentDiabetes MellitusElementsEthnic OriginFoundationsFrequenciesFutureHealth systemHealthcareHeart DiseasesHospitalizationHospitalsHourImmunosuppressive AgentsIncidenceInfectionInsulinIntegration Host FactorsIntervention TrialKidney DiseasesLaboratoriesLength of StayLog-Linear ModelsLogistic RegressionsMedical ElectronicsMichiganModelingNIH Program AnnouncementsNested Case-Control StudyObesityOralPacked Red Blood Cell TransfusionPatientsPharmaceutical PreparationsPharmacy facilityPreventivePreventive InterventionProceduresRaceRandom AllocationRecording of previous eventsRecordsResearchResistanceRiskRisk FactorsSamplingScreening procedureSepsisSlideSmokingTestingTimeTreatment FactorUltrasonographyUniversitiesUrinary RetentionUrinary tractUrinary tract infectionWeightWorkcase controlcohortdensityfootimprovedinterestmicrobialmicroorganismmortalitynovelolder patientoutcome forecastpublic health relevancesextoolurinaryward
项目摘要
DESCRIPTION (provided by applicant): Preventive efforts to reduce urinary tract-related bloodstream infection are hampered by the scarcity of analytic studies that identify etiologic factors, particularly those specific to the time-dependent elements that may impact prognosis during hospitalization. Therefore, the ability of clinicians to intercede in a meaningful way has been restricted. The objective of this study is to delineate both host- and time-dependent factors that contribute to urinary tract-related bloodstream infection in hospitalized patients. This study is unique in that it will ascertain potential causal mechanisms of bloodstream infection taking into account the time course of a hospitalized patient's stay and the multiple procedures and treatments that occur during this stay. Specific Aim #1 addresses the relation between obesity, diabetes, and urosepsis. Specific Aim #2 is directed to time-related procedural and treatment factors that impact the incidence of infection. Of particular interest are the use of catheterization, ultrasound detection of urinary retention, antibiotics, immunosuppressant therapies, statin use, and allogeneic blood transfusions. A nested case-control study is planned that will include adult patients from the University of Michigan Health System. Incidence density sampling will be utilized for random selection of controls. Information from cases and controls will be extracted from multiple electronic databases (electronic medical, pharmacy, and laboratory records) over a 5-year period to yield 640 subjects. Analyses will identify factors related to the development of urinary tract-related bloodstream infection in hospitalized patients. Conditional logistic regression with clustering by ward will be utilized for the analyses, as well as sliding time windows for log-linear models and cubic B-splines with time-specific weight functions. We anticipate that the information obtained from the proposed study which evaluates novel risk factors and is responsive to program announcement PA-06-151 by utilizing secondary data will enhance tools for clinical decision making and provide a framework for preventive trials. Urinary tract infection is the most frequent healthcare-associated infection and, when disseminated to the bloodstream, can be fatal. The mortality rate of urinary tract-related bloodstream infection varies from 5% to 33% in different cohorts and is considerably higher in elderly patients. We anticipate that the information obtained from this study will form the foundation for the development of screening tests to identify patients at risk of infection at specific points in time during hospitalization and for planning preventive intervention trials. PUBLIC HEALTH RELEVANCE: Urinary tract infection is the most frequent healthcare-associated infection and, when disseminated to the bloodstream, can be fatal. The mortality rate of urinary tract-related bloodstream infection varies from 5% to 33% in different cohorts and is considerably higher in elderly patients. We anticipate that the information obtained from this study will form the foundation for the development of screening tests to identify patients at risk of infection at specific points in time during hospitalization and for planning preventive intervention trials.
描述(由申请人提供):减少尿路相关血流感染的预防性努力受到缺乏确定病因因素的分析研究的阻碍,特别是那些可能影响住院期间预后的时间依赖性因素。因此,临床医生以有意义的方式进行调解的能力受到了限制。本研究的目的是描述两个主机和时间依赖性因素,有助于尿路相关的血流感染住院患者。这项研究的独特之处在于,它将确定血流感染的潜在因果机制,同时考虑到住院患者的住院时间以及住院期间发生的多种程序和治疗。具体目标#1解决肥胖、糖尿病和尿脓毒症之间的关系。具体目标#2针对影响感染发生率的时间相关手术和治疗因素。特别感兴趣的是导管插入术、尿潴留超声检测、抗生素、免疫抑制剂治疗、他汀类药物使用和同种异体输血的使用。计划进行一项巢式病例对照研究,其中包括密歇根大学卫生系统的成年患者。将使用发病密度采样随机选择对照。将从多个电子数据库(电子医疗、药房和实验室记录)中提取病例和对照的信息,为期5年,以获得640例受试者。分析将确定住院患者发生尿路相关血流感染的相关因素。分析将使用按病房聚类的条件logistic回归,以及对数线性模型和具有时间特异性权重函数的三次B样条的滑动时间窗。我们预计,从拟议的研究中获得的信息 它评估新的风险因素,并通过利用二级数据对计划公告PA-06-151做出响应, 将增强临床决策工具,并为预防性试验提供框架。尿路感染是最常见的卫生保健相关感染,当传播到血液中时,可能是致命的。尿路相关血流感染的死亡率在不同队列中从5%到33%不等,老年患者的死亡率相当高。我们预计,从本研究中获得的信息将成为开发筛选试验的基础,以确定住院期间特定时间点的感染风险患者,并计划预防性干预试验。公共卫生相关性:尿路感染是最常见的卫生保健相关感染,当传播到血液中时,可能是致命的。尿路相关血流感染的死亡率在不同队列中从5%到33%不等,老年患者的死亡率相当高。我们预计,从本研究中获得的信息将成为开发筛选试验的基础,以确定住院期间特定时间点的感染风险患者,并计划预防性干预试验。
项目成果
期刊论文数量(12)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Epidemiology of hospital-acquired urinary tract-related bloodstream infection at a university hospital.
- DOI:10.1086/662378
- 发表时间:2011-11
- 期刊:
- 影响因子:4.5
- 作者:Chang R;Greene MT;Chenoweth CE;Kuhn L;Shuman E;Rogers MA;Saint S
- 通讯作者:Saint S
Predictors of hospital-acquired urinary tract-related bloodstream infection.
医院获得性尿路相关血流感染的预测因素。
- DOI:10.1086/667731
- 发表时间:2012-10
- 期刊:
- 影响因子:4.5
- 作者:Greene MT;Chang R;Kuhn L;Rogers MA;Chenoweth CE;Shuman E;Saint S
- 通讯作者:Saint S
Effect of nonpayment for hospital-acquired, catheter-associated urinary tract infection: a statewide analysis.
- DOI:10.7326/0003-4819-157-5-201209040-00003
- 发表时间:2012-09-04
- 期刊:
- 影响因子:39.2
- 作者:Meddings JA;Reichert H;Rogers MA;Saint S;Stephansky J;McMahon LF
- 通讯作者:McMahon LF
Introducing the Patient Safety Professional: Why, What, Who, How, and Where?
- DOI:10.1097/pts.0b013e318230e585
- 发表时间:2011-12-01
- 期刊:
- 影响因子:2.2
- 作者:Saint, Sanjay;Krein, Sarah L.;Shojania, Kaveh G.
- 通讯作者:Shojania, Kaveh G.
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
SANJAY K SAINT其他文献
SANJAY K SAINT的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('SANJAY K SAINT', 18)}}的其他基金
Engineering Whole Health into Hospital Care to Improve Wellness: The M-Wellness Laboratory (M-Well)
将整体健康纳入医院护理以改善健康:M-Wellness 实验室 (M-Well)
- 批准号:
10677656 - 财政年份:2022
- 资助金额:
$ 22.8万 - 项目类别:
Predictors of Hospital-Acquired Urinary Tract-Related Bloodstream Infection in VA
VA 医院获得性尿路相关血流感染的预测因素
- 批准号:
8449947 - 财政年份:2012
- 资助金额:
$ 22.8万 - 项目类别:
Predictors of Hospital-Acquired Urinary Tract-Related Bloodstream Infection in VA
VA 医院获得性尿路相关血流感染的预测因素
- 批准号:
8698357 - 财政年份:2012
- 资助金额:
$ 22.8万 - 项目类别:
Predictors of Hospital-Acquired Urinary Tract-Related Bloodstream Infection in VA
VA 医院获得性尿路相关血流感染的预测因素
- 批准号:
8243948 - 财政年份:2012
- 资助金额:
$ 22.8万 - 项目类别:
Predictors of Hospital-Acquired Urinary Tract-Related Bloodstream Infection
医院获得性尿路相关血流感染的预测因子
- 批准号:
7468283 - 财政年份:2008
- 资助金额:
$ 22.8万 - 项目类别:
相似海外基金
Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
- 批准号:
MR/S03398X/2 - 财政年份:2024
- 资助金额:
$ 22.8万 - 项目类别:
Fellowship
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
- 批准号:
2338423 - 财政年份:2024
- 资助金额:
$ 22.8万 - 项目类别:
Continuing Grant
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
- 批准号:
EP/Y001486/1 - 财政年份:2024
- 资助金额:
$ 22.8万 - 项目类别:
Research Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
- 批准号:
MR/X03657X/1 - 财政年份:2024
- 资助金额:
$ 22.8万 - 项目类别:
Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
- 批准号:
2348066 - 财政年份:2024
- 资助金额:
$ 22.8万 - 项目类别:
Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
- 批准号:
AH/Z505481/1 - 财政年份:2024
- 资助金额:
$ 22.8万 - 项目类别:
Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10107647 - 财政年份:2024
- 资助金额:
$ 22.8万 - 项目类别:
EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
- 批准号:
2341402 - 财政年份:2024
- 资助金额:
$ 22.8万 - 项目类别:
Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10106221 - 财政年份:2024
- 资助金额:
$ 22.8万 - 项目类别:
EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
- 批准号:
AH/Z505341/1 - 财政年份:2024
- 资助金额:
$ 22.8万 - 项目类别:
Research Grant